| UniProt ID | TBA1C_HUMAN | |
|---|---|---|
| UniProt AC | Q9BQE3 | |
| Protein Name | Tubulin alpha-1C chain | |
| Gene Name | TUBA1C | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 449 | |
| Subcellular Localization | Cytoplasm, cytoskeleton. | |
| Protein Description | Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.. | |
| Protein Sequence | MRECISIHVGQAGVQIGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFNTFFSETGAGKHVPRAVFVDLEPTVIDEVRTGTYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDLVLDRIRKLADQCTGLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLISQIVSSITASLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLTVAEITNACFEPANQMVKCDPRHGKYMACCLLYRGDVVPKDVNAAIATIKTKRTIQFVDWCPTGFKVGINYQPPTVVPGGDLAKVQRAVCMLSNTTAVAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEKDYEEVGADSADGEDEGEEY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | O-linked_Glycosylation | --MRECISIHVGQAG --CCCEEEEEECCHH | 20.50 | 28510447 | |
| 6 | Phosphorylation | --MRECISIHVGQAG --CCCEEEEEECCHH | 20.50 | - | |
| 24 | Phosphorylation | GNACWELYCLEHGIQ CHHHHHCHHHHCCCC | 5.40 | - | |
| 38 | O-linked_Glycosylation | QPDGQMPSDKTIGGG CCCCCCCCCCCCCCC | 46.53 | 28510447 | |
| 38 | Phosphorylation | QPDGQMPSDKTIGGG CCCCCCCCCCCCCCC | 46.53 | 26074081 | |
| 40 | Acetylation | DGQMPSDKTIGGGDD CCCCCCCCCCCCCCC | 46.51 | 24906155 | |
| 40 | Ubiquitination | DGQMPSDKTIGGGDD CCCCCCCCCCCCCCC | 46.51 | 24906155 | |
| 41 | O-linked_Glycosylation | GQMPSDKTIGGGDDS CCCCCCCCCCCCCCC | 29.82 | 28510447 | |
| 41 | Phosphorylation | GQMPSDKTIGGGDDS CCCCCCCCCCCCCCC | 29.82 | 25463755 | |
| 48 | Phosphorylation | TIGGGDDSFNTFFSE CCCCCCCCHHHCCCC | 25.74 | 19664994 | |
| 51 | Phosphorylation | GGDDSFNTFFSETGA CCCCCHHHCCCCCCC | 24.85 | 29255136 | |
| 54 | Phosphorylation | DSFNTFFSETGAGKH CCHHHCCCCCCCCCC | 30.02 | 25159151 | |
| 56 | O-linked_Glycosylation | FNTFFSETGAGKHVP HHHCCCCCCCCCCCC | 31.00 | 28510447 | |
| 56 | Phosphorylation | FNTFFSETGAGKHVP HHHCCCCCCCCCCCC | 31.00 | 23927012 | |
| 60 | Sumoylation | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | - | |
| 60 | Acetylation | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | 19811241 | |
| 60 | Sumoylation | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | 19608861 | |
| 60 | Ubiquitination | FSETGAGKHVPRAVF CCCCCCCCCCCEEEE | 40.68 | 20639865 | |
| 73 | Phosphorylation | VFVDLEPTVIDEVRT EEECCCCEEEHHCCC | 22.25 | 30108239 | |
| 80 | O-linked_Glycosylation | TVIDEVRTGTYRQLF EEEHHCCCCCCHHCC | 38.77 | 28510447 | |
| 80 | Phosphorylation | TVIDEVRTGTYRQLF EEEHHCCCCCCHHCC | 38.77 | 28857561 | |
| 82 | Phosphorylation | IDEVRTGTYRQLFHP EHHCCCCCCHHCCCH | 18.21 | 28857561 | |
| 83 | Phosphorylation | DEVRTGTYRQLFHPE HHCCCCCCHHCCCHH | 9.56 | 28857561 | |
| 94 | O-linked_Glycosylation | FHPEQLITGKEDAAN CCHHHHCCCCHHHHH | 51.28 | 28510447 | |
| 94 | Phosphorylation | FHPEQLITGKEDAAN CCHHHHCCCCHHHHH | 51.28 | 28152594 | |
| 96 | Sumoylation | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | - | |
| 96 | Acetylation | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | 30584151 | |
| 96 | Sumoylation | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | - | |
| 96 | Ubiquitination | PEQLITGKEDAANNY HHHHCCCCHHHHHHC | 43.71 | 20639865 | |
| 103 | Phosphorylation | KEDAANNYARGHYTI CHHHHHHCCCCCCCC | 9.48 | 27155012 | |
| 108 | Phosphorylation | NNYARGHYTIGKEII HHCCCCCCCCCHHHH | 11.68 | 25884760 | |
| 109 | O-linked_Glycosylation | NYARGHYTIGKEIID HCCCCCCCCCHHHHH | 19.99 | 28510447 | |
| 109 | Phosphorylation | NYARGHYTIGKEIID HCCCCCCCCCHHHHH | 19.99 | 28796482 | |
| 112 | Sumoylation | RGHYTIGKEIIDLVL CCCCCCCHHHHHHHH | 41.72 | - | |
| 112 | Acetylation | RGHYTIGKEIIDLVL CCCCCCCHHHHHHHH | 41.72 | 19608861 | |
| 112 | Sumoylation | RGHYTIGKEIIDLVL CCCCCCCHHHHHHHH | 41.72 | 19608861 | |
| 112 | Ubiquitination | RGHYTIGKEIIDLVL CCCCCCCHHHHHHHH | 41.72 | 19608861 | |
| 124 | Acetylation | LVLDRIRKLADQCTG HHHHHHHHHHHHCCC | 45.73 | 156239 | |
| 124 | Ubiquitination | LVLDRIRKLADQCTG HHHHHHHHHHHHCCC | 45.73 | 21906983 | |
| 145 | O-linked_Glycosylation | FHSFGGGTGSGFTSL EEECCCCCCCCHHHH | 31.30 | 28510447 | |
| 147 | O-linked_Glycosylation | SFGGGTGSGFTSLLM ECCCCCCCCHHHHHH | 30.48 | 28510447 | |
| 151 | Phosphorylation | GTGSGFTSLLMERLS CCCCCHHHHHHHHHC | 19.76 | - | |
| 158 | Phosphorylation | SLLMERLSVDYGKKS HHHHHHHCCCCCCCC | 21.11 | 28355574 | |
| 161 | Phosphorylation | MERLSVDYGKKSKLE HHHHCCCCCCCCCEE | 28.79 | 23911959 | |
| 163 | Acetylation | RLSVDYGKKSKLEFS HHCCCCCCCCCEEEE | 47.87 | 129755 | |
| 163 | Methylation | RLSVDYGKKSKLEFS HHCCCCCCCCCEEEE | 47.87 | 129755 | |
| 163 | Ubiquitination | RLSVDYGKKSKLEFS HHCCCCCCCCCEEEE | 47.87 | 21890473 | |
| 164 | Ubiquitination | LSVDYGKKSKLEFSI HCCCCCCCCCEEEEE | 48.75 | 21906983 | |
| 165 | Phosphorylation | SVDYGKKSKLEFSIY CCCCCCCCCEEEEEE | 46.06 | 22817900 | |
| 166 | Ubiquitination | VDYGKKSKLEFSIYP CCCCCCCCEEEEEEE | 62.00 | - | |
| 170 | Phosphorylation | KKSKLEFSIYPAPQV CCCCEEEEEEECCCC | 16.31 | 23663014 | |
| 172 | Phosphorylation | SKLEFSIYPAPQVST CCEEEEEEECCCCCE | 7.67 | 23663014 | |
| 178 | Phosphorylation | IYPAPQVSTAVVEPY EEECCCCCEEEEECC | 12.85 | 23663014 | |
| 179 | Phosphorylation | YPAPQVSTAVVEPYN EECCCCCEEEEECCC | 25.31 | 23663014 | |
| 185 | Phosphorylation | STAVVEPYNSILTTH CEEEEECCCCCCCCC | 14.18 | 23663014 | |
| 187 | Phosphorylation | AVVEPYNSILTTHTT EEEECCCCCCCCCCC | 17.09 | 23663014 | |
| 190 | Phosphorylation | EPYNSILTTHTTLEH ECCCCCCCCCCCCCC | 18.18 | 23663014 | |
| 191 | Phosphorylation | PYNSILTTHTTLEHS CCCCCCCCCCCCCCC | 17.49 | 23663014 | |
| 193 | Phosphorylation | NSILTTHTTLEHSDC CCCCCCCCCCCCCCE | 30.86 | 23663014 | |
| 194 | Phosphorylation | SILTTHTTLEHSDCA CCCCCCCCCCCCCEE | 23.65 | 23663014 | |
| 198 | Phosphorylation | THTTLEHSDCAFMVD CCCCCCCCCEEEEEC | 25.63 | 26356563 | |
| 210 | Phosphorylation | MVDNEAIYDICRRNL EECHHHHHHHHHCCC | 13.30 | 25884760 | |
| 223 | Phosphorylation | NLDIERPTYTNLNRL CCCCCCCCHHCHHHH | 49.55 | 28796482 | |
| 224 | Phosphorylation | LDIERPTYTNLNRLI CCCCCCCHHCHHHHH | 9.05 | 19605366 | |
| 225 | O-linked_Glycosylation | DIERPTYTNLNRLIS CCCCCCHHCHHHHHH | 35.39 | 28510447 | |
| 225 | Phosphorylation | DIERPTYTNLNRLIS CCCCCCHHCHHHHHH | 35.39 | 28555341 | |
| 232 | Phosphorylation | TNLNRLISQIVSSIT HCHHHHHHHHHHHHH | 20.60 | 21712546 | |
| 236 | Phosphorylation | RLISQIVSSITASLR HHHHHHHHHHHHHCC | 20.04 | 23403867 | |
| 237 | Phosphorylation | LISQIVSSITASLRF HHHHHHHHHHHHCCC | 17.05 | 23403867 | |
| 239 | Phosphorylation | SQIVSSITASLRFDG HHHHHHHHHHCCCCC | 16.49 | 23403867 | |
| 241 | Phosphorylation | IVSSITASLRFDGAL HHHHHHHHCCCCCCC | 16.07 | 23403867 | |
| 253 | Phosphorylation | GALNVDLTEFQTNLV CCCCCCCCEEECCCC | 30.23 | 21712546 | |
| 257 | O-linked_Glycosylation | VDLTEFQTNLVPYPR CCCCEEECCCCCCCC | 35.52 | 28510447 | |
| 257 | Phosphorylation | VDLTEFQTNLVPYPR CCCCEEECCCCCCCC | 35.52 | 21712546 | |
| 262 | Phosphorylation | FQTNLVPYPRIHFPL EECCCCCCCCCCCCC | 9.54 | 22817901 | |
| 271 | O-linked_Glycosylation | RIHFPLATYAPVISA CCCCCCCCCCCCCCH | 28.09 | 28510447 | |
| 271 | Phosphorylation | RIHFPLATYAPVISA CCCCCCCCCCCCCCH | 28.09 | 21945579 | |
| 272 | Phosphorylation | IHFPLATYAPVISAE CCCCCCCCCCCCCHH | 11.87 | 21945579 | |
| 277 | O-linked_Glycosylation | ATYAPVISAEKAYHE CCCCCCCCHHHHHHH | 30.52 | 28510447 | |
| 277 | Phosphorylation | ATYAPVISAEKAYHE CCCCCCCCHHHHHHH | 30.52 | 21945579 | |
| 280 | Acetylation | APVISAEKAYHEQLT CCCCCHHHHHHHCCC | 54.70 | 88231 | |
| 280 | Ubiquitination | APVISAEKAYHEQLT CCCCCHHHHHHHCCC | 54.70 | - | |
| 282 | Nitrated tyrosine | VISAEKAYHEQLTVA CCCHHHHHHHCCCHH | 19.56 | - | |
| 282 | Nitration | VISAEKAYHEQLTVA CCCHHHHHHHCCCHH | 19.56 | - | |
| 282 | Phosphorylation | VISAEKAYHEQLTVA CCCHHHHHHHCCCHH | 19.56 | 22817900 | |
| 287 | Phosphorylation | KAYHEQLTVAEITNA HHHHHCCCHHHHHHH | 19.84 | - | |
| 292 | Phosphorylation | QLTVAEITNACFEPA CCCHHHHHHHHCCCH | 14.31 | 26126808 | |
| 295 | Glutathionylation | VAEITNACFEPANQM HHHHHHHHCCCHHHC | 4.27 | 22555962 | |
| 302 | Sulfoxidation | CFEPANQMVKCDPRH HCCCHHHCCCCCCCC | 2.89 | 30846556 | |
| 304 | Ubiquitination | EPANQMVKCDPRHGK CCHHHCCCCCCCCCC | 27.81 | 21906983 | |
| 311 | Acetylation | KCDPRHGKYMACCLL CCCCCCCCEEEEHHH | 26.23 | 129747 | |
| 311 | Ubiquitination | KCDPRHGKYMACCLL CCCCCCCCEEEEHHH | 26.23 | 21890473 | |
| 312 | Phosphorylation | CDPRHGKYMACCLLY CCCCCCCEEEEHHHC | 8.44 | 28152594 | |
| 315 | Glutathionylation | RHGKYMACCLLYRGD CCCCEEEEHHHCCCC | 0.67 | 22555962 | |
| 319 | Phosphorylation | YMACCLLYRGDVVPK EEEEHHHCCCCCCCC | 10.29 | 23917254 | |
| 326 | Sumoylation | YRGDVVPKDVNAAIA CCCCCCCCCCHHHHH | 63.80 | - | |
| 326 | Acetylation | YRGDVVPKDVNAAIA CCCCCCCCCCHHHHH | 63.80 | 22632557 | |
| 326 | Sumoylation | YRGDVVPKDVNAAIA CCCCCCCCCCHHHHH | 63.80 | - | |
| 326 | Ubiquitination | YRGDVVPKDVNAAIA CCCCCCCCCCHHHHH | 63.80 | 21906983 | |
| 334 | O-linked_Glycosylation | DVNAAIATIKTKRTI CCHHHHHHCCCCCEE | 19.52 | 28510447 | |
| 334 | Phosphorylation | DVNAAIATIKTKRTI CCHHHHHHCCCCCEE | 19.52 | 23401153 | |
| 336 | Sumoylation | NAAIATIKTKRTIQF HHHHHHCCCCCEEEE | 43.57 | - | |
| 336 | Acetylation | NAAIATIKTKRTIQF HHHHHHCCCCCEEEE | 43.57 | 134093 | |
| 336 | Sumoylation | NAAIATIKTKRTIQF HHHHHHCCCCCEEEE | 43.57 | - | |
| 336 | Ubiquitination | NAAIATIKTKRTIQF HHHHHHCCCCCEEEE | 43.57 | 20639865 | |
| 337 | Phosphorylation | AAIATIKTKRTIQFV HHHHHCCCCCEEEEE | 23.16 | 30266825 | |
| 338 | Methylation | AIATIKTKRTIQFVD HHHHCCCCCEEEEEE | 42.41 | 184699 | |
| 338 | Ubiquitination | AIATIKTKRTIQFVD HHHHCCCCCEEEEEE | 42.41 | 21906983 | |
| 340 | O-linked_Glycosylation | ATIKTKRTIQFVDWC HHCCCCCEEEEEEEC | 22.23 | 28510447 | |
| 340 | Phosphorylation | ATIKTKRTIQFVDWC HHCCCCCEEEEEEEC | 22.23 | 28857561 | |
| 347 | Glutathionylation | TIQFVDWCPTGFKVG EEEEEEECCCCEEEE | 1.55 | 22555962 | |
| 349 | Phosphorylation | QFVDWCPTGFKVGIN EEEEECCCCEEEEEE | 52.71 | 21712546 | |
| 352 | Acetylation | DWCPTGFKVGINYQP EECCCCEEEEEECCC | 40.68 | 129743 | |
| 352 | Sumoylation | DWCPTGFKVGINYQP EECCCCEEEEEECCC | 40.68 | - | |
| 352 | Ubiquitination | DWCPTGFKVGINYQP EECCCCEEEEEECCC | 40.68 | - | |
| 357 | Phosphorylation | GFKVGINYQPPTVVP CEEEEEECCCCEECC | 22.07 | 27273156 | |
| 361 | Phosphorylation | GINYQPPTVVPGGDL EEECCCCEECCCCCH | 40.60 | 28152594 | |
| 370 | Sumoylation | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | - | |
| 370 | Acetylation | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | 184703 | |
| 370 | Sumoylation | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | - | |
| 370 | Ubiquitination | VPGGDLAKVQRAVCM CCCCCHHHHHHHHHH | 46.31 | 21906983 | |
| 376 | Glutathionylation | AKVQRAVCMLSNTTA HHHHHHHHHHCCCHH | 1.90 | 22555962 | |
| 377 | Sulfoxidation | KVQRAVCMLSNTTAV HHHHHHHHHCCCHHH | 3.55 | 28465586 | |
| 379 | Phosphorylation | QRAVCMLSNTTAVAE HHHHHHHCCCHHHHH | 12.78 | 21712546 | |
| 381 | O-linked_Glycosylation | AVCMLSNTTAVAEAW HHHHHCCCHHHHHHH | 16.86 | 28510447 | |
| 382 | O-linked_Glycosylation | VCMLSNTTAVAEAWA HHHHCCCHHHHHHHH | 24.32 | 28510447 | |
| 394 | Sumoylation | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | - | |
| 394 | Acetylation | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | 134089 | |
| 394 | Sumoylation | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | - | |
| 394 | Ubiquitination | AWARLDHKFDLMYAK HHHHCCCCCCHHHEE | 39.99 | 21890473 | |
| 399 | Phosphorylation | DHKFDLMYAKRAFVH CCCCCHHHEEEHHHH | 19.10 | 28674151 | |
| 401 | Sumoylation | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | - | |
| 401 | Acetylation | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | 129751 | |
| 401 | Sumoylation | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | - | |
| 401 | Ubiquitination | KFDLMYAKRAFVHWY CCCHHHEEEHHHHHH | 27.11 | 21890473 | |
| 408 | Phosphorylation | KRAFVHWYVGEGMEE EEHHHHHHCCCCCCC | 5.45 | 28796482 | |
| 419 | O-linked_Glycosylation | GMEEGEFSEAREDMA CCCCCCHHHHHHHHH | 26.50 | 28510447 | |
| 419 | Phosphorylation | GMEEGEFSEAREDMA CCCCCCHHHHHHHHH | 26.50 | 28270605 | |
| 425 | Sulfoxidation | FSEAREDMAALEKDY HHHHHHHHHHHHHHH | 1.69 | 30846556 | |
| 430 | Ubiquitination | EDMAALEKDYEEVGA HHHHHHHHHHHHHCC | 67.47 | 21906983 | |
| 432 | Phosphorylation | MAALEKDYEEVGADS HHHHHHHHHHHCCCC | 25.67 | 28176443 | |
| 439 | Phosphorylation | YEEVGADSADGEDEG HHHHCCCCCCCCCCC | 27.94 | 25159151 | |
| 449 | Nitration | GEDEGEEY------- CCCCCCCC------- | 21.39 | - | |
| 449 | Phosphorylation | GEDEGEEY------- CCCCCCCC------- | 21.39 | 28176443 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBA1C_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-112, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-432 AND SER-439, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-439, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-439, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-41; SER-48; THR-51;THR-334 AND SER-439, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-439, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-357, AND MASSSPECTROMETRY. | |